<?xml version="1.0" encoding="UTF-8"?>
<p>Rabbits in both the vaccine and placebo groups were inoculated intramuscularly on week 0, 2 and 4 with a 30 Âµg dose of vaccine in 0.5 ml or 0.5 ml of PBS, respectively. The 6 rabbits in each group were further divided into two subgroups of 3 animals on week 6, and then challenged intravenously with 1 mL of either the genotype 4 swine HEV or the rabbit HEV inocula described above.</p>
